Suchergebnisse - "Hamladji, Rose-Marie"

PubPharm (44)

31

Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission

enthalten in: Oncotarget | 2018

von Saraceni, F. | Labopin, M. | Hamladji, R. | +14

32

Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2017

von Lucchini, G. | Labopin, M. | Beohou, E. | +20

33

Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen : a report from the EBMT Acute Leukemia Working Party

enthalten in: Journal of hematology & oncology | 2017

von Rubio, M. | D'Aveni-Piney, M. | Labopin, M. | +14

34

Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party

enthalten in: Journal of hematology & oncology | 2017

von Rubio, M. | D’Aveni-Piney, M. | Labopin, M. | +14

35

Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012 : A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT)

enthalten in: Hematology/oncology and stem cell therapy | 2015

von Aljurf, M. | Nassar, A. | Hamidieh, A. | +27

36

Higher busulfan dose intensity appears to improve leukemia-free and overall survival in AML allografted in CR2 : An analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

enthalten in: Leukemia research | 2015

von Kharfan-Dabaja, M. | Labopin, M. | Bazarbachi, A. | +12

CommentIn: Leuk Res. 2016 Feb;41:5-6. - PMID 26733443

37

Efficacy and outcome of allogeneic transplantation in IgD and nonsecretory myeloma. A report on behalf of the Myeloma Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2015

von Morris, C. | Iacobelli, S. | Gahrton, G. | +13

38

Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia : an EBMT analysis

enthalten in: Haematologica | 2015

von Bacigalupo, A. | Socié, G. | Hamladji, R. | +14

39

Higher busulfan dose intensity appears to improve leukemia-free and overall survival in AML allografted in CR2: An analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

enthalten in: Leukemia research | 2015

von Kharfan-Dabaja, M. | Labopin, M. | Bazarbachi, A. | +12

40

Who is the best hematopoietic stem-cell donor for a male patient with acute leukemia?

enthalten in: Transplantation | 2014

von Ringdén, O. | Labopin, M. | Solders, M. | +14